In bladder cancer, ERCC1 might become an important factor to predict cisplatin resistance as in other malignancies, and our in vitro results suggested that in some bladder cancer cells, ERCC1 expression correlates with resistance to IR but not with resistance to cisplatin. This evidence concerns the gene ERCC1 and urinary bladder cancer.